None listed
Conditions
Interventions
Medical Device : Randomized into groups 1,2,3 based on the first intervention method. Each group is divided into 6 groups (1-1, 1-2, 2-1, 2-2, 3-1, 3-2) according to the randomization.
group 1: optimi
Sponsors
Neurophet
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Subacute and chronic patients who have had a stroke for more than 4 weeks 2. Those who do not fall under the exclusion criteria for this clinical trial
Exclusion criteria
Exclusion criteria: 1. Those who fall under the contraindications of tDCS - A person whose location of metal material on the skull corresponds to the attachment site for clinical trial medical devices - Persons with artificial pacemakers, artificial valves, or ear implants (eg, cochlear implants) 2. Those who have medical contraindications for brain imaging (MRI) examination 3. Persons determined by the investigator to be unable to participate in this clinical trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MEP amplitude | — |
Secondary
| Measure | Time frame |
|---|---|
| MEP latency | — |
Countries
Korea, Republic of
Contacts
Public ContactHongyoung Kim
Kangwon National University Hospital
Outcome results
None listed